MedMen
Week in Review: New Ohio processing licenses, CA marijuana black market & Florida judge nixes MMJ business cap
Ohio awards provisional medical marijuana processing licenses, a cannabis consumer survey in California confirms licensed MJ businesses are losing market share to illicit operators, and a Florida judge says a state law restricting the number of MMJ businesses runs afoul of a voter-approved constitutional amendment.
Cannabis firm 4Front to go public after closing $13.4 million raise
Arizona-based 4Front Holdings is charting a path to go public in Canada following its latest $13.4 million funding round.
Corporate governance: 5 steps marijuana firms should take as they grow
Rapid growth across the cannabis industry is forcing thousands of firms to grow up fast – and it’s not always a smooth process. As companies hustle to gain market share and raise capital in an increasingly competitive environment, many are still playing catch up on basic corporate governance controls.
US marijuana company Green Thumb makes trading debut in Canada
Green Thumb Industries Wednesday joined the growing list of U.S. cannabis firms to go public in Canada’s booming marijuana market, with investors giving the stock an initial thumbs-up.
MedMen inks $53 million acquisition of Florida cannabis cultivator, dispensary sites
MedMen Enterprises has signed a deal to acquire a Florida-based cultivator and the right to open up to more than two dozen dispensaries across the state. The $53 million deal catapults MedMen into Florida’s growing medical marijuana market – a state expected to hit $1 billion in sales by 2020.
Five reasons why lighting giant Osram’s acquisition of Fluence is a big deal for cannabis
One of the cannabis industry’s largest lighting solutions suppliers, Austin, Texas-based Fluence Bioengineering was recently acquired by Osram, a $4.1 billion firm based in Munich, Germany. The deal may signal increased interest from international firms and investors on the hunt for ancillary cannabis companies.
What cannabis investors should know about MedMen’s Canadian trading debut
Los Angeles-based MedMen is the latest U.S. cannabis company to go public in Canada as more firms hustle to raise the capital needed to stay ahead in the green rush.The multistate marijuana firm debuted Tuesday on the Canadian Securities Exchange under the ticker MMEN.
